Press Releases
 
Statins Market Size & Share - Industry Trend and Forecast 2018 - 2026

, 6 December 2018 -- Statins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Statins are lipid lowering agents or medications used in the treatment of high lipid levels. These are often referred as high cholesterol found in the blood. The major function of statins is to lower blood cholesterol and prevent atherosclerosis. These drugs help to prevent heart attacks and strokes. These lower the production of cholesterol by blocking an enzyme known as HMG-CoA reductase used by liver. According to studies, statins have reduced heart attacks and strokes by 25% to 35%. Statins recommended by health care practitioners work well for patients with balanced nutritious food and exercise. Healthy lifestyle practices are essential to improve the quality of the patient’s life.

The global statins market is projected to grow at a rapid pace in the next few years. Sedentary lifestyle is a key driver of the market. High bad cholesterol is difficult to manage only on diet and exercise. Hence, statins are recommended to treat the condition. Increase in the patient population suffering from obesity, cardiovascular diseases, and diabetes propels demand for statins across the globe. Demand for effective treatment to reduce LDL cholesterol is also a major factor driving the global statins market. Cholesterol awareness campaigns and technologically advanced health care facilities increase demand for statins.

Companies are expanding market presence across the globe by establishing strong distribution networks, especially in developing countries. However, increase in demand for effective treatment alternatives acts as a major restraint of the market. Social and economic factors also hamper the global statins market. Switching patients on statins is a major challenge in the market. Side effects of statins can act as a restrain of the market. There are long term risks associated with usage of statins including depression, Alzheimer’s, dementia, and poor cognitive function. This lowers the demand for statins in the market. Common side effects of statins which affect a large population are muscle pain, muscle damage, liver damage, type 2 diabetes, and neurological disorders.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=51561

In terms of product class, the global statins market can be classified into atorvastatin (Lipitor & others), fluvastatin (Lescol, Canef, and Vastin), lovastatin (Mevacor & others), pravastatin (Pravachol), rosuvastatin (Crestor), simvastatin (Zocor), and pitavastatin (Livalo). Only 5 types of statins are available in the U.K., excluding lovastatin and pitavastatin. Availability of the drugs in different regions also directly impacts specific markets. Based on application, the market can be categorized into cardiovascular diseases (heart strokes & attacks), lifestyle diseases (obesity, diabetes, and inflammation), and others. In terms of end-user, the global statins market can be bifurcated into hospitals, clinics, and others.

In terms of region, the global statins market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017. The region held major market share due to increase in number of ###### suffering from LDL cholesterol. Rise in health care expenditure, technological advancements, and increase in incidence of lifestyle diseases also boost the growth of the market in North America. Comparatively, Asia Pacific is an emerging market due to increase in incidence in obesity and cardiovascular diseases, and changes in health care regulatory policies.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=51561

Major players operating in the global statins market are AstraZeneca, Merck & Co., Inc., Pfizer, Inc., Aurbindo Pharma, Amgen, GlaxoSmithKline plc, Biocon, and Concord Biotech, among others.

More Trending Reports by Transparency Market Research –

Implantable Medical Devices Market: https://www.prnewswire.com/news-releases/implantable-medical-devices-market-predicted-to-be-worth-us-49-8-bn-by-2024-says-tmr-894467337.html

Rheumatoid Arthritis Drugs Market: http://www.prnewswire.co.uk/news-releases/rheumatoid-arthritis-drugs-market-to-be-worth-us-267586-mn-by-2026-says-tmr-689965851.html

# # #


Submitted by hawer on Thursday, 6 December 2018 at 8:40 PM
Category: Health Care & Medical
 
Related News

Hereditary Angioedema Market - Rise in Hereditary Angioedema Attacks to Bolster the Demand
Wednesday, 16 Jan 2019

Diabetic Neuropathy Market is Rising at a Steady CAGR of 5.4% Between 2017 and 2025
Wednesday, 16 Jan 2019

Antibleeding Gel Market Growth Strategies and Comprehensive Forecast to 2024
Wednesday, 16 Jan 2019

Genomics in Cancer Care Market Outlook to 2024 Scrutinized in New Research
Wednesday, 16 Jan 2019

Hemophilia Management Market Research Available in New Report
Wednesday, 16 Jan 2019

Related Events

International Conference on Loss, Bereavement and Human Resilience - Israel
Monday, 14 Jan 2019

18th Annual Caribbean Dermatology Symposium
Tuesday, 15 Jan 2019

Pre-Filled Syringes And Injectable Drug Devices Europe
Wednesday, 16 Jan 2019

11th Annual ICJR Winter Hip and Knee Course, Vail 2019
Thursday, 17 Jan 2019

ICRS Summit, San Diego, 2019 - Bio/Orthopaedics in Sport Medicine
Thursday, 17 Jan 2019

Latest News

Hereditary Angioedema Market - Rise in Hereditary Angioedema Attacks to Bolster the Demand
Wednesday, 16 Jan 2019

Diabetic Neuropathy Market is Rising at a Steady CAGR of 5.4% Between 2017 and 2025
Wednesday, 16 Jan 2019

Antibleeding Gel Market Growth Strategies and Comprehensive Forecast to 2024
Wednesday, 16 Jan 2019

Genomics in Cancer Care Market Outlook to 2024 Scrutinized in New Research
Wednesday, 16 Jan 2019

Hemophilia Management Market Research Available in New Report
Wednesday, 16 Jan 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Wednesday, 16 January 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • International Conference on Loss, Bereavement and Human Resilience - Israel
  • SteelFab 2019
  • 18th Annual Caribbean Dermatology Symposium
  • Palo Alto Networks: CYBER TUESDAY – CYBER SECURITY BEST PRACTICES – LEVEL 1
  • Palo Alto Networks: GO FAST, STAY SECURE - Security for Public Clouds

  • Latest Jobs
    Sorry, there are currently no entries posted here.